Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Tomas Hanke
Tomas Hanke
Professor
The University of Oxford
United Kingdom
Biography

Prof. Tomas Hanke is a Professor of Immunology at the University of Oxford and a Distinguished Immunology Professor at Kumamoto University in Japan. His research aims to develop a universal HIV-1 vaccine, which targets most global virus variants including escape mutants. He explores novel vaccine modalities and optimizes their immunogenicity in heterelogous prime-boost regimens in mice and macaques. He co-ordinates a clinical program assessing candidate HIV vaccines in humans in UK, Europe and Africa. You can read more information about his work: The proposed work under Advancing HIV Therapeutic Vaccine Science (U01) will work cooperatively with academic institutions, industry and NIAID to conduct a coordinated research program to test a first-in-human trial of candidate T-cell vaccines tHIVconsvX. I am delighted to participate as an investigator on this proposal. My research aims to develop a universal HIV-1 vaccine that targets most global virus variants including escape mutants. This is achieved by focusing the vaccine-elicited responses on the most conserved regions of the HIV-1 proteins, which are common to most global variants and typically decrease the virus replicative fitness if mutated. Global coverage is enhanced by a bivalent mosaic design. Overall, I strive to maintain a balance between basic and translational research. I oversee a busy pre-clinical programme encompassing HIV-1 epitope discovery and dynamics using mass spectrometry and T-cell assays, studies on immunodominance, depth (number of variants) of epitope recognition, and the importance of perfect vaccine-virus epitope matching for effective effector functions. I also explore novel vaccine modalities and optimize their immunogenicity in heterelogous prime-boost regimens in mice and macaques. I co-ordinate a clinical programme assessing candidate HIV-1 vaccines in humans in UK, Europe and Africa. I look forward to working with PI Dr. Goonetilleke, U01 colleagues and NIAID to conduct the proposed clinical trial in parallel with my other clinical program, advancing this vaccine strategy to characterize the elicited responses and their protective potential, with the ultimate goal to discover HIV prevention and cure.

Research Interest

Professor Perera’s primary research program focuses on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions. In the last five years, his research focus has turned to managing chronic conditions. He is currently PI on an NIHR (UK) funded Programme grant on Monitoring Long term conditions in Primary Care, focusing on improving the evidence for the management of Chronic Kidney Disease and Chronic Heart Failure. He is the author of more than 150 publications focusing on monitoring in primary care, meta-analysis methods, methodology for studying infectious diseases in children, and assessing complex interventions.

Allied Academies Global Conference Directory

Mail us at

Enquiry
stdaids@alliedevents.org
General Queries
stdaids@alliedevents.org
Sponsors/Exhibitors
stdaids@alliedevents.org
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility

The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

Insurance

No insurance, of any kind, is included along with the registration in any of the events of the organization.

Transportation

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

 

Press/Media

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party non-profit organization and this conference is not associated with any commercial meeting company.

 

Requesting an Invitation Letter

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact infectiousdiseases@alliedconferences.org to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

 

Cancellation Policy

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com

 

Postponement of event

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Transfer of registration

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to contact@alliedacademies.com . Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.

This cancellation policy was last updated on April 04, 2015.

 

Visa Information

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

  • Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.
  • Within 60-30 days of Conference: Eligible for 50% of payment Refund
  • Within 30 days of Conference: Not eligible for Refund
  • E-Poster Payments will not be refunded.

 

Accommodation Cancellation Policy:

Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

Authorization Policy

Copyright © 2018-2019 Allied Academies, All Rights Reserved.